Randomized,Open Label,Two-cycle,Crossover,Single Dose Bioequivalency Study of Two Preparations of CM082 Tablet in Healthy Chinese Volunteers Under Fasted State and After Meal
Latest Information Update: 29 Nov 2021
At a glance
- Drugs Vorolanib (Primary)
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors AnewPharma
- 24 Nov 2021 Status changed from recruiting to completed.
- 02 Apr 2020 New trial record